Pathstone Family Office, LLC Cognition Therapeutics Inc Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
A detailed history of Pathstone Family Office, LLC transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Pathstone Family Office, LLC holds 2,205,377 shares of CGTX stock, worth $4.01 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,205,377
Previous 2,205,377
-0.0%
Holding current value
$4.01 Million
Previous $4.04 Million
21.31%
% of portfolio
0.02%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding CGTX
# of Institutions
51Shares Held
9.4MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD1.9MShares$3.45 Million1.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA922KShares$1.68 Million0.0% of portfolio
-
Awm Investment Company, Inc. New York, NY650KShares$1.18 Million0.18% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$910,0000.01% of portfolio
-
Timelo Investment Management Inc.481KShares$874,8390.34% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $41.3M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...